Literature DB >> 5125386

Endocrine function and glucose metabolism in patients with Parkinson's disease and their alternation by L-Dopa.

A E Boyd, H E Lebovitz, J M Feldman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5125386     DOI: 10.1210/jcem-33-5-829

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  16 in total

1.  Effects of unilateral nigrostriatal dopamine depletion on peripheral glucose tolerance and insulin signaling in middle aged rats.

Authors:  J K Morris; N B Seim; G L Bomhoff; P C Geiger; J A Stanford
Journal:  Neurosci Lett       Date:  2011-09-21       Impact factor: 3.046

2.  Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease.

Authors:  J K Morris; H Zhang; A A Gupte; G L Bomhoff; J A Stanford; P C Geiger
Journal:  Brain Res       Date:  2008-09-11       Impact factor: 3.252

3.  Management of parkinson's disease--combined therapy with levodopa and thalamotomy.

Authors:  J A Mosso; R W Rand
Journal:  West J Med       Date:  1975-01

4.  Possibility of autocrine beta-adrenergic signaling in C2C12 myotubes.

Authors:  Jill L Smith; Pankaj B Patil; Shelley D Minteer; Jason R Lipsitz; Jonathan S Fisher
Journal:  Exp Biol Med (Maywood)       Date:  2005-12

5.  Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet.

Authors:  Jill K Morris; Gregory L Bomhoff; John A Stanford; Paige C Geiger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-08-11       Impact factor: 3.619

6.  Endocrine aspects of bromocriptine therapy in Parkinsonism.

Authors:  K M Shaw; A J Lees; S Franks; P Daggett; B D Thompson; G M Stern
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

7.  Functional evaluation of prolactin secretion in patients with hypothalamic-pituitary disorders.

Authors:  G Tolis; M Goldstein; H G Friesen
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

Review 8.  Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer's Disease and Other Neurodegenerative Diseases.

Authors:  Valeria Calsolaro; Paul Edison
Journal:  CNS Drugs       Date:  2015-12       Impact factor: 5.749

9.  Effect of increased pancreatic islet norepinephrine, dopamine and serotonin concentration on insulin secretion in the golden hamster.

Authors:  R T Zern; J L Bird; J M Feldman
Journal:  Diabetologia       Date:  1980-04       Impact factor: 10.122

10.  Role of vitamin d in Parkinson's disease.

Authors:  Khanh L Ng; Lan Nguyễn
Journal:  ISRN Neurol       Date:  2012-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.